t-cells

Documents about t-cells

• T-cells or EBV Specific CTLs, Advanced B-Cell NHL and CLL#969610ClinicalTrials.gov
• Corrigendum to: Differential antigenic requirements by diverse MR1-restricted T cells (Immunology & Cell Biology, (2022), 100, 2, (112-126), 10.1111/imcb.12519)#1005338The University of Melbourne Library Digital Repository
• CD30 CAR for CD30+ NSGCT#1008049ClinicalTrials.gov
• Phase I Study of Autologous CD8+ and CD4+ Engineered T Cell Receptor T Cells in Subjects With Advanced or Metastatic Solid Tumor#912606ClinicalTrials.gov
• Modified Immune Cells (CD19/CD20 CAR-T Cells) in Treating Patients With Recurrent or Refractory B-Cell Lymphoma or Chronic Lymphocytic Leukemia#125823ClinicalTrials.gov
• CAR2219 CAR-T Cells for the Treatment of R/R B Cell Leukemia and Lymphoma#1032395ClinicalTrials.gov
• Genetically Modified T-cells (CMV-Specific CD19-CAR T-cells) Plus a Vaccine (CMV-MVA Triplex) Following Stem Cell Transplantation for the Treatment of Intermediate or High Grade B-cell Non-Hodgkin Lymphoma#141101ClinicalTrials.gov
• 19(T2)28z1xx Chimeric Antigen Receptor (CAR) T Cells in People With B-Cell Cancers#826141ClinicalTrials.gov
• Harnessing conserved epitopes and multivalent antigen strategies for vaccine design: Lessons learned and opportunities#4499Europe PMC
• Enhanced expression of HLA-DR and CD69 on peripheral CD4 ⁺ T cells predicts better clinical outcomes in cutaneous melanoma#133103Unpaywall
• CD8+ Antigen-Specific T Cells, Cyclophosphamide, Aldesleukin, and Ipilimumab in Treating Patients With Metastatic Melanoma#160361ClinicalTrials.gov
• The 1000 + mouse project for largescale spatiotemporal parametrization and modeling of preclinical cancer immunotherapies#274263HAL (France)
• IL-17-producing CD8 ⁺ T cells differ in phenotype, metabolic profile and cytokine production to their CD4 ⁺ Th17 counterparts#291360Europe PMC
• TNFR2 is expressed by a discrete subset of epidermal T cells with an IL-17 gene signature during psoriasis#305595PLOS
• Correction: Harmonisation of quality control tests for academic production of CAR-T cells: a position paper from the WP-bioproduction of the UNITC consortium#312070HAL (France)
• Sequential involvement of hypoxia and anti-PD-1 treatment in shaping tumor-regional CD39(+)CD8(+) T cells highlights immunotherapy-resistant features in NSCLC.#323041NCBI PubMed Central
• A Clinical Research of CAR T Cells Targeting EpCAM Positive Cancer#332745ClinicalTrials.gov
• Blood cytotoxic natural killer-like CD8 + CD94+ T cells migrate to the brain and predict multiple sclerosis severity#408762HAL (France)
• Study of αPD1-MSLN-CAR T Cells to Evaluate the Safety, Tolerability, and Effectiveness for Patients With MSLN-positive Advanced Solid Tumors#460088ClinicalTrials.gov
• In vitro assessment of the cytotoxicity and genotoxicity of herbal mouthrinses on human oral fibroblast cells#471144Animo Repository
• Evaluate TCRT-ESO-A2 Autologous T Cells Expressing TCR Specific for NY-ESO-1 in Subjects With Advanced Solid Tumors#828913ClinicalTrials.gov
• UF-KURE-BCMA CAR-T Cells in Patients With Relapsed or Refractory Multiple Myeloma#875952ClinicalTrials.gov
• Ph I/II Study of CAR19 Regulatory T Cells (CAR19-tTreg) for R/R CD19+ B-ALL#884515ClinicalTrials.gov
• Phase II Study of Anti-CD19 CAR-T Cells Treating Leukemia Children#886634ClinicalTrials.gov
• A Phase I Trial of Memory T Cells Expressing an NKG2D Chimeric Antigen Receptor in Children, Adolescents and Young Adults With Advanced Sarcoma#900302ClinicalTrials.gov
• Exploratory Study of MSLN-CAR T Cells Secreting PD1/CTLA-4 Nanoantibody for the Treatment of Advanced Solid Tumors#966316ClinicalTrials.gov
• Phase I Trial Integrating HLA-Haploidentical Anti-CD19 CAR-T Cells With Post-Transplantation Cyclophosphamide-Based HLA-Haploidentical Hematopoietic Cell Transplantation#862796ClinicalTrials.gov
• Sequential Infusion of CD146-Targeted and HER2-Targeted CAR T Cells in Patients With Advanced Sarcomas#868016ClinicalTrials.gov
• CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma#876910ClinicalTrials.gov
• Master Protocol to Assess the Safety and Antitumor Activity of Genetically Engineered T Cells in NY-ESO-1 and/or LAGE-1a Positive Solid Tumors#979170ClinicalTrials.gov
• A Study of YTS109 Cell Injection in Subjects With Relapsed/Refractory Autoimmune Hemolytic Anemia#869671ClinicalTrials.gov
• T-Cell Infusion, Aldesleukin, and Utomilumab in Treating Patients With Recurrent Ovarian Cancer#172290ClinicalTrials.gov
• Preventative/Preemptive Adoptive Transfer of Peptide Stimulated CMV/EBV Specific T-cells in Patients After Allogeneic Stem Cell Transplantation#180369ClinicalTrials.gov
• A Phase I Trial of T Cells Expressing an Anti-GD2 Chimeric Antigen Receptor in Children and Young Adults With GD2+ Solid Tumors#321694ClinicalTrials.gov
• GPC3 CAR T Cells With IL-15 and IL-21 for Recurrent ATRT and CNS Rhabdoid Tumors (RADIANT)#369834ClinicalTrials.gov
• Pooling across cells to normalize single-cell RNA sequencing data with many zero counts#400295OpenAlex
• Safety and Efficacy of Allogeneic HPV-specific T Cells in Adults With Recurrent or Metastatic HPV16+ Cancers#441971ClinicalTrials.gov
• A symposium update on the key perspectives in systemic sclerosis and systemic lupus erythematosus#448828HAL (France)
• SAP loss limits anti-insulin atypical B cell activation and pro-inflammatory CD8 T cells despite preserved Tfh responses to protect against type 1 diabetes#623298bioRxiv / medRxiv
• Filling the Gap: The Immune Therapeutic Armamentarium for Relapsed/Refractory Hodgkin Lymphoma#643031HAL (France)
• DBP rs7041 and DHCR7 rs3829251 are Linked to CD4+ Recovery in HIV Patients on Antiretroviral Therapy#646700Repisalud
• Immunotherapy With BCMA CAR-T Cells in Treating Patients With BCMA Positive Relapsed or Refractory Multiple Myeloma#830407ClinicalTrials.gov
• Therapeutic Evaluation of Low-dose IL-2-based Immunomodulatory Approach in Patients With Early AD#843618ClinicalTrials.gov
• A Study of BMS-986482 Alone or as Combination Therapy in Participants With Advanced Solid Tumors#856663ClinicalTrials.gov
• Study of Single Doses of SBT777101 in Subjects With Rheumatoid Arthritis#889831ClinicalTrials.gov
• Clinical Study of CAR-BCMA T Cells in Patients With Refractory or Relapsed Multiple Myeloma#898441ClinicalTrials.gov
• Analysis T Cells Response for Identification of Aspergillus Bronchitis With Cystic Fibrosis Patients#904908ClinicalTrials.gov
• Intermediate-size IND for Treatment of Patients With Advanced Cancer Using T Cells Engineered to Express TCR Targeting Mutant KRAS#1009751ClinicalTrials.gov
• Mycophenolate Mofetil and Cyclosporine to Treat Relapsing Aplastic Anemia#1031572ClinicalTrials.gov
• Table 1_Immunomodulatory effects of HUC-MSCs therapy: enhancing adaptive and innate immune responses in aging frailty.xlsx#361734Figshare